Get the tools used by (smart)2 investors.

Neurocrine Biosciences IncNASDAQGS:NBIX

United States / Healthcare / Biotechnology

Join now and get access to the full platform

Exchange Data

Summary of Neurocrine Biosciences Inc

Hide this widget

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the ...

Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Peer Benchmarks

Hide this widget
  NBIX Peers Sector
Market Cap
10.56 B191.6 M67.235 M
Price % of 52 Week High
67.6%47.6%61.5%
Dividend Yield
0.0%0.0%0.0%
Shareholder Yield
1.1%-27.6%-0.6%
1 Year Price Total Return
-21.5%-29.2%-11.2%
Beta (5 Year)
0.330.940.64

In the News

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GREAT
Financial Health for Neurocrine is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.

Financial Models for Neurocrine Biosciences Inc

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue1,4891,8872,355515628
Operating Income249395583150131
Net Profit155250341148103
Diluted EPS1.562.473.291.451
EBITDA265416610156138
Balance Sheet
Cash & ST Invest.9891,0321,0761,0321,076
Current Assets1,4541,6071,7251,6071,725
Total Assets2,3693,2513,7193,2513,719
Current Liabilities538655508655508
Total Liabilities6611,0191,1291,0191,129
Total Equity1,7082,2322,5902,2322,590
Total Debt263428496428496
Cash Flow Statement
Cash Flow Operations339390595124243
Cash From Investing(177)(467)(127)(202)(68)
Cash From Financing(234)65(487)35(290)
Free Cash Flow323362557118235

Analyst Notes

April 26, 2025
Hide this widget
    All rights reserved. Terms Of Use